Clinical trials: Developmental Stuttering
Persistent Developmental Stuttering
EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
The objective of the study is to determine the effects of pagoclone on the symptoms of Persistent Developmental Stuttering, using a flexible dosing titration regimen on persistent developmental stuttering in patients 18 to 65…
- Trial name
- NCT00216255
- Testing
- Pagoclone
- Where
- 16 sites in United States
- Volunteers
- 120 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Persistent Developmental Stuttering
Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)
This is a research study of the investigational drug, Pagoclone, in the treatment of persistent developmental stuttering (PDS), which includes frequent repetitions or prolongations of sounds or syllables or words, or frequent…
- Trial name
- NCT00239915
- Testing
- Pagoclone
- Where
- United States
- Sponsor
- Pharmacology Research Institute
Stuttering, Developmental Apraxia of Speech
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
Subjects' utterances were submitted to acoustic analysis before and after the intervention program applied on prosodic basis.
- Trial name
- SAS:EIP (NCT01097161)
- Testing
- speech therapy with the assistance of an acoustical analysis program
- Where
- Brazil
- Volunteers
- 4 people
- Sponsor
- Federal University of Minas Gerais